Michelle Min, MD, MS, reviewed best practices for managing cutaneous lupus and discussed emerging therapies practitioners ...
Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...
Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...
Tralokinumab for AD was associated with sustained improvements in disease severity and no new safety signals at 12 months in a real-life study.
Congenital TORCH infections appear to be associated with an increased risk for intellectual disability and autism.
Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them are FDA-approved.
BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents ...
An active acupressure intervention offers clinical benefits for patients with rosacea when combined with pharmacotherapy.
Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...
Undeclared pharmacologically active ingredients are detected in one-third of over-the-counter skin products marketed online.
Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results